Cargando…
Updates on Oxaliplatin-Induced Peripheral Neurotoxicity (OXAIPN)
Oxaliplatin-induced peripheral neuropathy (OXAIPN) is of great clinical interest as it ranks among the most common dose limiting toxicities of oxaliplatin (OXA) administration with an obvious impact on the outcome of cancer patients. In addition, OXAIPN has a detrimental effect on the quality of lif...
Autor principal: | Argyriou, Andreas A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5634688/ https://www.ncbi.nlm.nih.gov/pubmed/29056657 http://dx.doi.org/10.3390/toxics3020187 |
Ejemplares similares
-
Predictive Biomarkers of Oxaliplatin-Induced Peripheral Neurotoxicity
por: Velasco, Roser, et al.
Publicado: (2021) -
Chemotherapy-induced peripheral neuropathy—part 2: focus on the prevention of oxaliplatin-induced neurotoxicity
por: Sałat, Kinga
Publicado: (2020) -
Targeting OCT2 with Duloxetine to Prevent Oxaliplatin-induced Peripheral Neurotoxicity
por: Nepal, Mahesh R., et al.
Publicado: (2022) -
Efficacy of Exercise Rehabilitation Program in Relieving Oxaliplatin Induced Peripheral Neurotoxicity
por: Gui, Qi, et al.
Publicado: (2021) -
Oxaliplatin-induced peripheral neurotoxicity in colorectal cancer patients: mechanisms, pharmacokinetics and strategies
por: Cheng, Fang, et al.
Publicado: (2023)